 and Real-Time PCR (qPCR) Market - Global Outlook and Forecast 2020-2025-1606127285.jpg)
Have a question?
Please get in touch with our team in case of any queries
dPCR AND qPCR MARKET SIZE TO CROSS USD 8 BILLION BY 2025, GROWING AT A CAGR OF 9% DURING THE FORECAST PERIOD
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share, & Trends Analysis Report By Technology (Real-Time PCR and Digital PCR), Product (Systems/Analyzers & Software and Consumables), Application (Clinical, Research, and Forensic), End-user (Hospitals, Diagnostic Laboratories, Research Laboratories, Pharma & Biotech Companies, Forensic Laboratories, and Others), and Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2025
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL Digital PCR (dPCR) and Real-time PCR (qPCR) MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| MARKET SIZE (REVENUE) | USD 8 BILLION (2025) |
| CAGR | 9 % (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020–2025 |
| Market Segments | Technology (Real Time PCR and Digital PCR), Product (Systems/Analyzers & Software and Consumables), Application (Clinical, Research, and Forensic), End-user (Hospitals, Diagnostic Laboratories, Research Laboratories, Pharma & Biotech Companies, Forensic Laboratories, and Others) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, and Turkey |
INDUSTRY INSIGHTS
The global Digital PCR (dPCR) and Real-time PCR (qPCR) market size are to be valued at USD 8 billion by the end of 2025, growing at a CAGR of over 9% during the forecast period. The digital PCR market size is expected to grow at a CAGR of over 11.5% during the forecast period. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing segments in the diagnostic and life sciences industries. The dPCR and the qPCR market are growing at a significant rate due to the rising incidence of infectious diseases and genetic disorders, continuous technological advancements in PCR technologies, the successful completion of the human genome project, and increasing R&D investments, funds, and grants as well as the increasing use of biomarker profiling for disease diagnostics. The surge in the growth can also be attributed to the growing prevalence/incidence of epidemics and pandemics such as the COVID-19 pandemic.
The introduction of automated analyzers with advanced connectivity, and high throughput, reduced waiting time and portability, the increase in the accuracy of the devices with the usage of the PCR specific test kits, ability to perform a large volume of tests in a shorter duration of time are expected to influence the market. Moreover, continued efforts by manufacturers to develop novel dPCR and qPCR systems and kits to use in molecular testing are likely to further propel the growth of the dPCR and qPCR market. New systems are expected to offer highly automated workflows and quick turnaround times than the current digital PCR platforms, which are likely to provide a significant competitive advantage.
SNIPPETS
- The digital PCR segment is expected to grow at a CAGR of over 11.5% during the forecast period as dPCRs are increasingly replacing real-time PCRs in the human genome project.
- The consumable segment is likely to reach a revenue share of close to $6 billion by 2025 due to the recurring usage of consumables for performing PCR tests.
- The clinical end-user segment is projected to observe an incremental growth of close to $1.8 billion by 2025 on account of the effective detection of bacteria by real-time PCR assays.
- The diagnostic segment is expected to grow at the highest CAGR of 10% during the period 2019–2025 due to the widespread application of PCR assays in diagnostic laboratories.
- The APAC region is likely to register the fastest CAGR of over 11% during the period 2019–2025 because of increased government support, awareness of advanced, accurate diagnosis PCR assays, and the high prevalence of infectious diseases.
GLOBAL dPCR AND qPCR MARKET SEGMENTATION
This research report market includes a detailed segmentation by
- Technology
- Product
- Application
- End-user
- Geography
INSIGHTS BY TECHNOLOGY
In 2019, the Real-time PCR (qPCR) segment dominated the market and accounted for a share of over 90%. One of the major reasons for the dominance of qPCRs is that they are widely used in infectious disease diagnosis and research projects. Real-time PCRs (qPCRs) has been well-established as credible and capable technology and are relied upon by researchers for their speed, sensitivity, specificity, and convenience. Several laboratories in developing countries are upgraded their infrastructure and technical training to perform PCR-based diagnosis for infectious diseases, thereby driving the segment growth.
The Digital PCR (dPCR) segment is slowly gaining momentum in the market, and dPCRs are accepted as an advanced technology among researchers. dPCRs are replacing qPCR in the human genome project and other sequencing studies and ongoing cancer research. In the current scenario, both technologies play a vital role in the market. PCR technologies as a whole – real-time and digital – show significant promise for driving growth in the future. While qPCR products continue to serve a real purpose in research labs, dPCR impressive levels of sensitivity, precision, robustness, and reproducibility are helping researchers propel their work beyond previous limits.
INSIGHTS BY PRODUCT
The usage of a wide array of several standard reagents and test kits to perform several PCR-based tests is a significant factor responsible for the growth of the consumable segment. The usage of consumables is reoccurring in nature, generating continuous revenue for vendors. Therefore, several renowned vendors are manufacturing consumables for PCR instruments. In recent years, the demand for consumables has been increasing at a significant rate; hence, vendors are offering a wide array of reagents and other associated consumables to perform a range of procedures. Both global and local/regional players offer a diverse range of consumables catering to the end-users requirements. The high prevalence of several infectious diseases across the globe has increased the demand for PCRs.
The instrument segment includes both Digital PCR (dPCR) and Real-time PCR (qPCR), which are used to perform multiple tests in pharma and biotech, research labs, diagnostic labs, academic institutes, etc. As the demand for instruments is growing, vendors are coming with several new technologies which offer connectivity, remote access, portability, and automation. As the life span of analyzers and other equipment is higher, they do not require repetitive purchase. Vendors consider them as a one-time investment from end-users. The sale of the latest instruments/analyzers is higher in developed countries than in developing and underdeveloping countries. Several emerging economies such as China, India, and Brazil are observing an increased uptake of diagnostics equipment such as PCR, which is likely to influence the market segment.
INSIGHTS BY APPLICATION
The clinical end-user segment dominates the market as PCRs play a significant role in detecting DNA methylation, recognizing viruses and protozoa in infectious diseases, estimating of gene copy number aberrations, and primer extension. The application of qPCR is high in the clinical application end-user segment due to the high cost of dPCR. As real-time PCR assays offer immediate results for the detection of bacteria, clinicians can confirm the infection status of the patient more rapidly than culture methods, allowing more specific and timely administration of appropriate therapy. The research application segment is limited to users in developed countries. The segment accounted for a share of over 44% in the global dPCR and qPCR market. Gene expression, genotyping, sequencing cloning, mutagenesis, and methylation are the major applications for PCRs in the research segment.
INSIGHTS BY END-USER
Diagnostic laboratories are the largest end-user of PCR instruments and consumables than other segments. They use PCR instruments for diagnosis purposes. Commercial and public health laboratories prefer the latest diagnostic equipment. Their investment focuses on advanced equipment for accurate results to attract customers. Private laboratories have expanded their footprints, especially in developing countries, which has stimulated growth prospects. Moreover, the demand for standalone reference laboratories is growing gradually owing to the prevalence of pandemic conditions, or the outbreak of unexpected infectious diseases, requiring immediate diagnosis of the diseases for the large population in a shorter period.
In 2019, the hospital segment accounted for a share of over 23% in the global dPCR and qPCR market. Laboratories are the exclusive units in hospitals. Around 92% of hospitals operate with their own laboratories. They are one of the largest end-users of PCR instruments and consumables as these settings perform a wide range of diagnostics testing. The availability of skilled healthcare professionals with knowledge and expertise in treating and diagnosing such conditions also attracts more patients to hospitals than in other healthcare settings, thereby influencing the digital PCR and real-time PCR market share.
INSIGHTS BY GEOGRAPHY
In 2019, North America accounted for a market share of 45% of the global digital PCR (dPCR) and real-time PCR (qPCR) market. Several factors are responsible for the growth of the market in the region. However, the increase in the target population and the high incidence of several infectious disease diagnostics are driving the PCR demand. There has been increasing in the prevalence of sexually transmitted diseases in North America. In 2018, over 37,832 people were confirmed HIV positive in the US and other states. A significant increase in several infectious diseases such as hepatitis, TB, and HIV was reported in the US alone. Approximately every 3 minutes, one person in the US is diagnosed with blood cancer. An estimated 176,200 people in the United States are diagnosed with leukemia, lymphoma, or myeloma in 2019. The government expenditure on clinical diagnostics & laboratory services has grown by 3% during the period 2010–2017, reaching $96.6 billion. Advances in technology are likely to increase the role of PCR tests in detecting, treating, and monitoring diseases. PCR is widely used in hospital setups as the conventional technique of culture-based disease diagnosis requires long isolation time and hospital admission.
INSIGHTS BY VENDORS
The global Digital PCR (dPCR) and Real-time PCR (qPCR) market is highly dynamic with the presence of global, regional, and local players, offering a diverse range of analyzers, software, and reagents for end-users. Agilent Technologies, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, QIAGEN, Takara Biotech, and Thermo Fisher Scientific are the key players operating in the global dPCR and qPCR market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers are continuously focusing on product launches & development and offering PCR instruments and software with new features to increase their market presence.
Vendors are focusing on developing and commercializing innovative analyzers, dPCR, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the market. New product approvals/launches coupled with R&D activities help vendors to expand their presence, enhance market growth during the forecast period, and sustain their market position in the global qPCR and dPCR market.
The Digital PCR (dPCR) and Real-time PCR (qPCR) market research report include in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
By Product
- Systems/Analyzers & Software
- Consumables
By Application
- Clinical
- Research
- Forensic
By Technology
- Real-Time PCR
- Digital PCR
By End-user
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Pharma & Biotech Companies
- Forensic Laboratories
- Others
By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- South Korea
- Australia
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
Frequently Asked Questions
What is the Digital PCR (dPCR) and Real-time PCR (qPCR) market size in 2020?
What are the factors impacting the growth of the dPCR and qPCR market share?
What is the growth of the digital PCR market?
Who are the leading vendors in the dPCR and qPCR market, and what are their market shares?
What is the impact of the COVID-19 pandemic on the dPCR and qPCR market share?
The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025.
The following factors are likely to contribute to the growth of the dPCR and qPCR market during the forecast period:
- Surge in Demand for PCR Tests due to COVID-19
- Increase in Demand for POC PCR Diagnostics
- Prevalence of Infectious Disease and Genetic Disorder
- Advances in PCR Technology
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the dPCR and qPCR market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
- Agilent Technologies Inc.
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- Quidel
- QIAGEN
- Takara Bio
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Danaher
- F.Hoffmann-La Roche
Other Prominent Vendors
- Abbott
- Business Overview
- Product Offerings
- BD
- bioMérieux
- Convergent Technologies
- FLUIDIGM
- Promega
- Analytik Jena Group
- Meridian Bioscience
- Eppendorf
- Enzo Life Sciences
- BIONEER
- ELITechGroup
- Quantabio
- Sacace Biotechnologies
- Bio Molecular Systems
- Biomeme
- JN Medsys
- Anitoa Systems
- ACTGene
- Mylab Discovery Solutions
- Amplyus
- Blue-Ray Biotech
- PentaBase
- Hologic
- GenMark Diagnostics
- Luminex
- Mobidiag
- PathoFinder
- Acupath Laboratories
- ALTRU DIAGNOSTICS
- Altona Diagnostics
- BGI
- BioCore
- Fosun Pharma
- General Biologicals Corporation (GBC)
- GeneStore
- Gnomegen
- KogeneBiotech
Segmentation by Product
- Systems/Analyzers & Software
- Consumables
Segmentation by Application
- Clinical
- Research
- Forensic
Segmentation by Technology
- Real Time PCR (qPCR)
- Digital PCR (dPCR)
Segmentation by End-user
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Pharma & Biotech Companies
- Forensic Laboratories
- Others
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- Japan
- South Korea
- Australia
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
List Of Exhibits
Exhibit 1 Segmentation of Global qPCR and dPCR Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of Surge in the Demand for PCR Tests due to COVID-19
Exhibit 4 Number of Tests Conducted in Various Key Countries – (As of June 2020 - millions)
Exhibit 5 Impact of Increase in the Demand for POC PCR Diagnostics
Exhibit 6 Impact of Paradigm Shift towards the Usage of dPCR
Exhibit 7 Impact of Increase in the Prevalence of Infectious Diseases and Genetic Disorders
Exhibit 8 Global Number of Human Infectious Disease Outbreak and Pathogen Taxonomy (past four decades comparison)
Exhibit 9 Impact of Technological Advancements in PCR
Exhibit 10 Impact of Expanding Application of PCR Post Human Genome Project
Exhibit 11 Impact of Technical Limitations of PCR
Exhibit 12 Impact of High Cost of PCR
Exhibit 13 Impact of Low Penetration of PCR Instruments in LMICs
Exhibit 14 Availability of the Healthcare Service
Exhibit 15 Global qPCR and dPCR Market 2019–2025 ($ million)
Exhibit 16 Five Forces Analysis 2019
Exhibit 17 Incremental Growth by Technology 2019 & 2025
Exhibit 18 Global qPCR and dPCR Market by Technology
Exhibit 19 Global qPCR and dPCR Market by Technology: Incremental Growth
Exhibit 20 Global qPCR and dPCR Market by Technology: Absolute Growth
Exhibit 21 Global qPCR and dPCR Market by Real-Time PCR: Incremental Growth versus Absolute Growth
Exhibit 22 Global qPCR and dPCRMarket– Real-Time PCR 2019–2025 ($ million)
Exhibit 23 Global qPCR and dPCR Market by Digital PCR: Incremental Growth versus Absolute Growth
Exhibit 24 Global qPCR and dPCR Market – Digital PCR 2019–2025 ($ million)
Exhibit 25 Incremental Growth by Product 2019 & 2025
Exhibit 26 Global qPCR and dPCR Market by Product
Exhibit 27 Global qPCR and dPCR Market by Product: Incremental Growth
Exhibit 28 Global qPCR and dPCR Market by Product: Absolute Growth
Exhibit 29 Global qPCR and dPCR Market by Consumables: Incremental Growth versus Absolute Growth
Exhibit 30 Global qPCR and dPCR Market - Consumables 2019–2025 ($ million)
Exhibit 31 Global qPCR and dPCR Market by Systems/Analyzers & Software: Incremental Growth versus Absolute Growth
Exhibit 32 Global qPCR and dPCR Market – Systems/Analyzers & Software 2019–2025 ($ million)
Exhibit 33 Incremental Growth by Application 2019 & 2025
Exhibit 34 Global qPCR and dPCR Market by Application
Exhibit 35 Global qPCR and dPCR Market by Application: Incremental Growth
Exhibit 36 Global qPCR and dPCR Market by Application: Absolute Growth
Exhibit 37 Global qPCR and dPCR Market by Clinical Applications: Incremental Growth versus Absolute Growth
Exhibit 38 Global qPCR and dPCR - Clinical Applications 2019–2025 ($ million)
Exhibit 39 Global qPCR and dPCR Market by Research Applications: Incremental Growth versus Absolute Growth
Exhibit 40 Global qPCR and dPCR - Research Applications 2019–2025 ($ million)
Exhibit 41 Workflow in Forensic DNA Analysis
Exhibit 42 Global qPCR and dPCR - Forensic Applications 2019–2025 ($ million)
Exhibit 43 Incremental Growth by End-user 2019 & 2025
Exhibit 44 Global qPCR and dPCR Market by End-User
Exhibit 45 Global qPCR and dPCR Market by End-User: Incremental Growth
Exhibit 46 Global qPCR and dPCR Market by End-User: Absolute Growth
Exhibit 47 Global qPCR and dPCR Market by Diagnostic Laboratories: Incremental Growth versus Absolute Growth
Exhibit 48 Global qPCR and dPCR Market- Diagnostic Laboratories 2019–2025 ($ million)
Exhibit 49 Global qPCR and dPCR Market by Hospitals: Incremental Growth versus Absolute Growth
Exhibit 50 Global qPCR and d PCR Market- Hospitals 2019–2025 ($ million)
Exhibit 51 Global qPCR and dPCR Market by Research Laboratories: Incremental Growth versus Absolute Growth
Exhibit 52 Global qPCR and dPCR Market- Research Laboratories 2019–2025 ($ million)
Exhibit 53 Global qPCR and dPCR Market by Pharma and Biotech Companies: Incremental Growth versus Absolute Growth
Exhibit 54 Global qPCR and d PCR Market- Pharma and Biotech Companies 2019–2025 ($ million)
Exhibit 55 Global qPCR and dPCR Market by Forensic Laboratories: Incremental Growth versus Absolute Growth
Exhibit 56 Global qPCR and d PCR Market – Forensic Laboratories 2019–2025 ($ million)
Exhibit 57 Global qPCR and dPCR Market by Others: Incremental Growth versus Absolute Growth
Exhibit 58 Global qPCR and d PCR Market- Others 2019–2025 ($ million)
Exhibit 59 Incremental Growth by Geography 2019 & 2025
Exhibit 60 Global qPCR and dPCR Market by Geography
Exhibit 61 Global qPCR and dPCR Market by Geography: Incremental Growth
Exhibit 62 Global qPCR and dPCR Market by Geography: Absolute Growth
Exhibit 63 Real-time PCR and Digital PCR Market in North America: Key Countries 2019 ($ million)
Exhibit 64 Real-time PCR and Digital PCR Market in North America: Incremental Growth versus Absolute Growth Comparison
Exhibit 65 qPCR and dPCR Market in North America 2019–2025 ($ million)
Exhibit 66 Incremental Growth in North America 2019 & 2025
Exhibit 67 US Laboratory Types and Test Volumes
Exhibit 68 qPCR and dPCR Market in US 2019–2025 ($ million)
Exhibit 69 qPCR and dPCR Market in Canada 2019–2025 ($ million)
Exhibit 70 Real-time PCR and Digital PCR Market in Europe: Key Countries 2019 ($ million)
Exhibit 71 Real-time PCR and Digital PCR Market in Europe: Incremental Growth versus Absolute Growth Comparison
Exhibit 72 qPCR and dPCR Market in Europe 2019–2025 ($ million)
Exhibit 73 Incremental Growth in Europe 2019 & 2025
Exhibit 74 qPCR and dPCR Market in Germany 2019–2025 ($ million)
Exhibit 75 qPCR and dPCR Market in France 2019–2025 ($ million)
Exhibit 76 qPCR and dPCR PCR Market in UK 2019–2025 ($ million)
Exhibit 77 qPCR and dPCR Market in Italy 2019–2025 ($ million)
Exhibit 78 qPCR and dPCR Market in Spain 2019–2025 ($ million)
Exhibit 79 Real-time PCR and Digital PCR Market in APAC: Key Countries 2019 ($ million)
Exhibit 80 Real-time PCR and Digital PCR Market in APAC: Incremental Growth versus Absolute Growth Comparison
Exhibit 81 qPCR and dPCR Market in APAC 2019–2025 ($ million)
Exhibit 82 Incremental Growth in APAC 2019 & 2025
Exhibit 83 qPCR and d PCR Market in Japan 2019–2025 ($ million)
Exhibit 84 qPCR and dPCR Market in China 2019−2025($ million)
Exhibit 85 qPCR and dPCR Market in Australia 2019−2025($ million)
Exhibit 86 qPCR and dPCR Market in South Korea 2019–2025 ($ million)
Exhibit 87 qPCR and dPCR Market in India 2019−2025($ million)
Exhibit 88 Real-time PCR and Digital PCR Market in Latin America: Key Countries 2019 ($ million)
Exhibit 89 Real-time PCR and Digital PCR Market in Latin America: Incremental Growth versus Absolute Growth Comparison
Exhibit 90 qPCR and d PCR Market in Latin America 2019–2025 ($ million)
Exhibit 91 Incremental Growth in Latin America 2019 & 2025
Exhibit 92 qPCR and dPCR Market in Brazil 2019–2025 ($ million)
Exhibit 93 qPCR and d PCR Market in Mexico 2019–2025 ($ million)
Exhibit 94 qPCR and dPCR Market in Argentina 2019–2025 ($ million)
Exhibit 95 Real-time PCR and Digital PCR Market in Middle East and Africa: Key Countries 2019 ($ million)
Exhibit 96 Real-time PCR and Digital PCR Market in Middle East and Africa: Incremental Growth versus Absolute Growth Comparison
Exhibit 97 qPCR and dPCR Market in Middle East and Africa 2019–2025 ($ million)
Exhibit 98 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 99 qPCR and d PCR Market in Turkey 2019–2025 ($ million)
Exhibit 100 qPCR and dPCR Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 101 qPCR and dPCR Market in South Africa 2019–2025 ($ million)
Exhibit 102 qPCR and dPCR Market in UAE 2019–2025 ($ million)
Exhibit 103 Agilent Technologies Revenue by Business Segment 2017−2019 ($ million)
Exhibit 104 Agilent Technologies Total Revenue 2017−2019 ($ million)
Exhibit 105 Agilent Technologies - Research and Development Expenses 2017−2019 ($ million)
Exhibit 106 QIAGEN Total Revenue 2017−2019 ($ million)
Exhibit 107 QIAGEN Research and Development Expenditure 2017−2019 ($ million)
Exhibit 108 QIAGEN Revenue by Product Categories 2017−2019 ($ million)
Exhibit 109 Takara Bio Revenue 2017−2019 ($ million)
Exhibit 110 Takara Bio R&D Expenditure 2017−2019 ($ million)
Exhibit 111 Thermo Fisher Scientific: Revenue 2017−2019 ($ million)
Exhibit 112 Thermo Fisher Scientific: R&D Expenditure 2017−2019 ($ million)
Exhibit 113 Thermo Fisher Scientific: Revenue by Geography ($ million)
Exhibit 114 Bio-Rad Laboratories Revenue 2017−2019 (billion)
Exhibit 115 Danaher: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 116 Danaher: Net Sales 2017−2019 ($ million)
Exhibit 117 Danaher: Revenue by Geography 2019
Exhibit 118 Danaher: R&D Expenditure 2017−2019 ($ million)
Exhibit 119 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)
Exhibit 120 F. Hoffmann-La Roche: Revenue by Geographical Segment 2018 & 2019 ($ billion)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 List of Few POC PCR Equipment
Table 4 List of Significant Vendors offering PCR in the Market
Table 5 Cost of PCR Machines
Table 6 Cost of PCR Machines based on blocks
Table 7 Cost Comparison of Traditional Microbiological technique and PCR Technology
Table 8 Applications and Advantages of Real-Time PCR
Table 9 Applications and Advantages of Digital PCR
Table 10 List of PCR Consumables
Table 11 Agilent Technologies: Major Product Offerings
Table 12 Quidel: Major Product Offerings
Table 13 Qiagen: Major Product Offerings
Table 14 Takara Bio: Major Product Offerings
Table 15 Thermo Fisher Scientific: Major Product Offerings
Table 16 Bio-Rad Laboratories: Major Product Offerings
Table 17 Danaher: Major Product Offerings
Table 18 F. Hoffmann-La Roche: Major Product Offerings
Table 19 ABBOTT: Major Product Offerings
Table 20 BD: Major Product Offerings
Table 21 bioMérieux: Major Product Offerings
Table 22 Convergent Technologies: Major Product Offerings
Table 23 FLUIDIGM: Major Product Offerings
Table 24 Promega: Major Product Offerings
Table 25 Analytik Jena Group: Major Product Offerings
Table 26 Meridian Bioscience: Major Product Offerings
Table 27 Eppendorf: Major Product Offerings
Table 28 Enzo Life Sciences: Major Product Offerings
Table 29 BIONEER: Major Product Offerings
Table 30 ELITechGroup: Major Product Offerings
Table 31 Quantabio: Major Product Offerings
Table 32 Sacace Biotechnologies: Major Product Offerings
Table 33 Bio Molecular Systems: Major Product Offerings
Table 34 Biomeme: Major Product Offerings
Table 35 JN Medsys: Major Product Offerings
Table 36 Anitoa Systems: Major Product Offerings
Table 37 ACTGene: Major Product Offerings
Table 38 Mylab Discovery Solutions: Major Product Offerings
Table 39 Amplyus: Major Product Offerings
Table 40 Blue-Ray Biotech Major Product Offerings
Table 41 PentaBase: Major Product Offerings
Table 42 Hologic: Major Product Offerings
Table 43 GenMark Diagnostics: Major Product Offerings
Table 44 Luminex: Major Product Offerings
Table 45 Mobidiag: Major Product Offerings
Table 46 PathoFinder: Major Product Offerings
Table 47 Acupath Laboratories: Major Product Offerings
Table 48 ALTRU DIAGNOSTICS: Major Product Offerings
Table 49 Altona Diagnostics: Major Product Offerings
Table 50 BGI: Major Product Offerings
Table 51 BioCore: Major Product Offerings
Table 52 Fosun Pharma: Major Product Offerings
Table 53 General Biologicals: Major Product Offerings
Table 54 GeneStore: Major Product Offerings
Table 55 Gnomegen: Major Product Offerings
Table 56 KogeneBiotech: Major Product Offerings
Table 57 Global qPCR and dPCR Market by Geography 2019−2025 ($ million)
Table 58 Global qPCR and dPCR Market by Geography 2019−2025 (%)
Table 59 Global qPCR and dPCR Market by End-User 2019−2025 ($ million)
Table 60 Global qPCR and dPCR Market by End-User 2019−2025 (%)
Table 61 Global qPCR and dPCR Market by Technology 2019−2025 ($ million)
Table 62 Global qPCR and dPCR Market by Technology 2019−2025 (%)
Table 63 Global qPCR and dPCR Market by Product 2019−2025 ($ million)
Table 64 Global qPCR and dPCR Market by Product 2019−2025 (%)
Table 65 Global qPCR and dPCR Market by Application 2019−2025 ($ million)
Table 66 Global qPCR and dPCR Market by Application 2019−2025 (%)
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation by Technology
4.3.2 Market Segmentation by Product
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Evolution of PCR
7.2 COVID-19 Pandemic
7.2.1 Overview
8 Market Opportunities & Trends
8.1 Surge In The Demand For PCR Tests Due To Covid-19
8.2 Increase In The Demand For Point-Of-Care (POC) PCR Diagnostics
8.3 Paradigm Shift Towards The Usage Of dPCR
9 Market Growth Enablers
9.1 Increase In The Prevalence Of Infectious Diseases And Genetic Disorders
9.2 Technological Advancements In PCR
9.3 Expanding Application Of PCR Post Human Genome Project
10 Market Restraints
10.1 Technical Limitations Of PCR
10.2 High Cost Of PCR
10.3 Low Penetration Of PCR Instruments In LMICs
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Technology
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Real-Time PCR
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Digital PCR
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Product
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Consumables
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Systems/Analyzers & Software
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Clinical Applications
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Research Applications
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Forensic Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Diagnostic Laboratories
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Research Laboratories
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Pharma & Biotech Companies
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Forensic Laboratories
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 US: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Japan: Market Size & Forecast
19.3.2 China: Market Size & Forecast
19.3.3 Australia: Market Size & Forecast
19.3.4 South Korea: Market Size & Forecast
19.3.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil : Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East And Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 Turkey: Market Size & Forecast
21.3.2 Saudi Arabia: Market Size & Forecast
21.3.3 South Africa: Market Size & Forecast
21.3.4 UAE: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Agilent Technologies
22.2.2 Bio-Rad Laboratories
22.2.3 Danaher
22.2.4 F. Hoffmann-La Roche
22.2.5 Quidel
22.2.6 Qiagen
22.2.7 Takara Bio
22.2.8 Thermo Fisher Scientific
23 Key Company Profiles
23.1 Agilent Technologies
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Quidel
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Qiagen
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Takara Bio
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Thermo Fisher Scientific
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Bio-Rad Laboratories
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Danaher
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 F. Hoffmann-La Roche
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities
24 Other Prominent Vendors
24.1 Abbott
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 BD
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 bioMérieux
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Convergent Technologies
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 FLUIDIGM
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Promega
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Analytik Jena Group
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Meridian Bioscience
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Eppendorf
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Enzo Life Sciences
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Bioneer
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 ELITechGroup
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Quantabio
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 SACACE Biotechnologies
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Bio Molecular Systems
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Biomeme
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 JN Medsys
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Anitoa Systems
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 ACTGene
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Mylab Discovery Solutions
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 Amplyus
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Blue-Ray Biotech
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 PentaBase
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 Hologic
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 GenMark Diagnostics
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 Luminex
24.26.1 Business Overview
24.26.2 Product Offerings
24.27 Mobidiag
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 PathoFinder
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 Acupath Laboratories
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 ALTRU Diagnostics
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 Altona Diagnostics
24.31.1 Business Overview
24.31.2 Product Offerings
24.32 BGI
24.32.1 Business Overview
24.32.2 Product Offerings
24.33 BioCore
24.33.1 Business Overview
24.33.2 Product Offerings
24.34 Fosun Pharma
24.34.1 Business Overview
24.34.2 Product Offerings
24.35 GenerAl Biologicals
24.35.1 Business Overview
24.35.2 Product Offerings
24.36 GeneStore
24.36.1 Business Overview
24.36.2 Product Offerings
24.37 Gnomegen
24.37.1 Business Overview
24.37.2 Product Offerings
24.38 KogeneBiotech
24.38.1 Business Overview
24.38.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market By Geography
26.2 Market By End-User
26.3 Market By Technology
26.4 Market By Product
26.5 Market By Application
27 Appendix
27.1 Abbreviations
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the Digital PCR (dPCR) and Real-time PCR (qPCR) market size in 2020?
What are the factors impacting the growth of the dPCR and qPCR market share?
What is the growth of the digital PCR market?
Who are the leading vendors in the dPCR and qPCR market, and what are their market shares?
What is the impact of the COVID-19 pandemic on the dPCR and qPCR market share?
other RELATED Reports
Benign Prostatic Hyperplasia Devices Market - Global Outlook and Forecast 2020-2025
Published : December 2020
COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026
Published : December 2020